Neurological soft signs as predictors of treatment response to selective serotonin reuptake inhibitors in obsessive-compulsive disorder

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 17, Issue 4, 2005, Pages 472-477

  Hollander, Eric ^a   Kaplan, Alicia ^b   Schmeidler, James ^b   Yang, Haichen ^b   Li, David ^b   Koran, Lorrin M ^b   Barbato, Luigi M ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUVOXAMINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROLOGIC DISEASE; OBSESSIVE COMPULSIVE DISORDER; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TASK PERFORMANCE; TREATMENT OUTCOME;

EID: 29044444464     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.17.4.472     Document Type: Article

References (24)

1. McKeon J, McGuffin P, Robinson P: Obsessive-compulsive neurosis following head injury: a report of 4 cases. Br J Psychiatry 1984; 144:190-192
2. Schilder P: The organic background of obsessions and compulsions. Am J Psychiatry 1938; 94:1397
3. Swedo SE, Rappaport JL, Cheslow DL, et al: High prevalence of obsessive-compulsive symptoms in patients with syndenham's chorea. Am J Psychiatry 1989; 146:246-249
4. Pauls DL, Towbin KE, Leckman JF et al: Gilles de la Tourette's syndrome and obsessive-compulsive disorder, evidence supporting a genetic relationship. Arch Gen Psychiatry 1986; 43:1180-112
5. Saxena S, Rauch SL: Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psych Clin North Am 2000; 23:563-586
6. Baer L, Rauch SK, Ballantine T, et al: Cingulotomy for intractable obsessive compulsive disorder. Arch Gen Psychiatry 1995; 43:384-392
7. Greenberg BD, George MS, Martin DJ, et al: Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study. Am J Psychiatry 1997; 154:867-869
8. Greenberg BD, Murphy DL, Rasmussen SA: Neuroanatomically based approaches to obsessive-compulsive disorder. Psych Clin North Am 2000; 23:671-686
9. Goodman WK, McDougle CJ, Barr LC, et al: Biological approaches to treatment-resistant OCD. J Clin Psychiatry 1993; 54:16-26
10. Mataix-Cols D, Rauch SL, Manzo PA, et al: Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry 1999; 156:1409-1416
11. Leckman JF, Zhang H, Alsobrook JP, et al: Symptom dimensions in obsessive-compulsive disorder: toward quantitative phenotypes. Am J Med Genetics 2001; 105:28-30
12. McDougle CJ, Goodman WK, Price LH: Dopamine antagonists in tic-related and psychotic spectrum obsessive-compulsive disorder. J Clin Psychiatry 1994, 53(suppl 3):24-31
13. Hollander E, Schiffman E, Cohen B, et al: Signs of central nervous system dysfunction in obsessive-compulsive disorder. Arch Gen Psychiatry 1990; 47:27-32
14. Hollander E, DeCaria CM, Saoud JB, et al: Reply to neurologic soft signs in obsessive-compulsive disorder. Arch Gen Psychiatry 1991; 48:278-279
15. Bihari K, Pato MT, Hill JL, et al: Neurologic soft signs in obsessive-compulsive disorder. Arch Gen Psych 1991; 46 278-79
16. Dazzan P, Murray DM: Neurological soft signs in first-episode psychosis: a systematic review. Br J Psychiatry 2002; 43(Sept suppl):50-57
17. Shaffer D, Schonfeld IS, O'Connor PA, et al: Neurological soft signs and their relationship to psychiatric disorder and intelligence in childhood and adolescence. Arch Gen Psychiatry 1985; 42:342-351
18. Leask SJ, Done DJ, Crow TJ: Adult psychosis, common childhood infections and neurological soft signs in a national birth cohort. Br J Psychiatry. 2002 Nov; 181:387-392
19. Heinrichs DW, Buchanan RW: Significance and meaning of neurological signs in schizophrenia. Am J Psychiatry 1988; 145: 11-18
20. Hollander E, Koran LM, Goodman W, et al: A double-blind, placebo-controlled study of the efficacy and safety of controlled release fluvoxamine in patients with obsessive compulsive disorder. J Clin Psychiatry 2003; 64:640-647
21. Scarone S, Colombo C, Livian S, et al: Increased right caudate nucleus size in obsessive-compulsive disorder: Detection with magnetic resonance imaging, Psychiatry Res 1992; 45115-121
22. Baxter LR, Jr, Schwartz JM, Bergman KS, et al: Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49: 681-689
23. Swedo SE, Schapiro MG, Grady CL, et al: Cerebral glucose metabolism in childhood onset obsessive-compulsive disorder. Arch Gen Psychiatry 1989; 46:518-523
24. Lippitz BE, Mindus P, Meyerson BA, et al: Lesion topography and outcome after thermocapsulotomy or gamma knife capsulotomy for obsessive-compulsive disorder: revelance of the right hemisphere. Neurosurgery 1999; 44:452-458; discussion 458-60